000 | 01391 a2200349 4500 | ||
---|---|---|---|
005 | 20250515091706.0 | ||
264 | 0 | _c20110712 | |
008 | 201107s 0 0 eng d | ||
022 | _a1989-2284 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGonzález Posada, J M | |
245 | 0 | 0 |
_aCurrent trends in immunosuppression. _h[electronic resource] |
260 |
_bNefrologia : publicacion oficial de la Sociedad Espanola Nefrologia _c2006 |
||
300 |
_a3-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
650 | 0 | 4 | _aCalcineurin Inhibitors |
650 | 0 | 4 | _aDisease Susceptibility |
650 | 0 | 4 |
_aGraft Rejection _xprevention & control |
650 | 0 | 4 |
_aGraft vs Host Disease _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppression Therapy _xmethods |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
650 | 0 | 4 | _aMulticenter Studies as Topic |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 |
_aSirolimus _xtherapeutic use |
650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
773 | 0 |
_tNefrologia : publicacion oficial de la Sociedad Espanola Nefrologia _gvol. 26 Suppl 2 _gp. 3-8 |
|
999 |
_c17458101 _d17458101 |